Ryan Caron King / Connecticut Public
Transportation workers, mail carriers, teachers, first responders, grocery store employees and others are positioned to be the next groups of people eligible for a COVID-19 vaccine in Connecticut.
State officials said during a public meeting Tuesday that the state’s Phase 1B vaccination distribution could begin as early as this month and include up to 800,000 workers and residents.
“Not too many more than that, because that allows us to have a somewhat manageable phase size,” said Benjamin Bechtolsheim, COVID-19 vaccination program director at the state Department of Public Health. “We think that that’s something that can be accomplished in roughly 10 weeks of a vaccine rollout.”
LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L, AZN) said Wednesday that its Farxiga has been granted priority review in the US for the treatment of new or worsening chronic kidney disease in adults
Changes to Hippocampus Key in Alzheimer’s Disease
Research led by researchers within the Neuroimaging Group UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) has found that specific subregions within the hippocampus may be key in understanding Alzheimer’s disease.
The hippocampus is one of the regions in the brain that has been frequently used in the diagnosis of Alzheimer’s disease – the most common type of dementia – with hippocampal volume an important biomarker of the disease. Genetic risk of Alzheimer’s disease is also indicated by hippocampal atrophy.
However, its structure is not uniform and is actually separated into subregions. These subregions have been observed to be influenced by genetics as well as age and sex.